Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S286-286
- https://doi.org/10.1016/s0959-8049(99)81569-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: